FHL2 and cancer: We further show through an analysis of other ovarian sex cord-stromal tumors and 33 different cancer types that this FHL2-GLI2 fusion is likely pathognomonic for SSTs, providing a genotypic-phenotypic correlation in ovarian neoplasms.